2025 Interventional Neurology Reading List

Reading List

Please click below to access the 2025 Interventional Neurology reading list.

C-cert Activity Description

The Continuous Certification (C-cert) activities provide subspecialty learning and knowledge assessment to ensure that diplomates are staying up to date on the latest science, treatments, and therapeutics relating to their subspecialty. The annual activities include: 1) reading the subspecialty  journal articles, and 2) taking and passing the 25-question online post-reading quiz to assess knowledge gained from the journal article content. 

Learning Objectives

• Advise patients and families about the current state and potential indication of thrombectomy in patients with LVO and a rapid resolving neurologic deficit
• Discuss the latest literature regarding the risk and benefit of thrombectomy in ELVOP due to ICAD
• Explain the extended indication for thrombectomy in patients with LCI
• Assess the alternative of intrasaccular flow disruption devices like the WEB embolization device in the aneurysm treatment armamentarium
• Recognize venous variants that better inform endovascular treatment decisions

Core Competencies

• Medical Knowledge
• Patient Care
• Practice-Based Learning and Improvement

Continuing Medical Education (CME) Instructions

To claim CME credits, answer question 26 on the quiz to reflect the total time spent completing the required reading and online quiz. This question is not included in the scoring of the quiz. A passing score of 80% of higher is needed to meet C-cert requirements and receive CME credit. CME credit confirmation will be emailed within 24 hours of passing the quiz.

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Neurology Institute (AANI) and United Council for Neurologic Subspecialties. The AANI is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement

The American Academy of Neurology Institute designates this enduring material for a maximum of 15 AMA PRA Category 1^TM credit(s). Physicians should claim only their credit commensurate with the extent of the participation in the activity.

ABPN Self-Assessment Designation Statement

The American Board of Psychiatry and Neurology (ABPN) has reviewed the UCNS Continuous Certification (C-cert) self-assessment activity and has approved this activity as part of a comprehensive self-assessment (SA) CME activity, which is mandated by the American Board of Medical Specialties (ABMS) as a necessary component of continuing certification.

Disclosures

The UCNS complies with all standards and policies of the ACCME, including identification and resolution of all conflicts of interest prior to the educational activity being delivered to learners. Accordingly, UCNS  planners, authors, and staff comply with the UCNS’s Conflicts of Interest Policy. 

2025 C-cert Activity Planner (Certification Council) Disclosures
All relevant financial relationships have been mitigated.

Interventional Neurology Certification Examination Committee Contributors

Alberto Maud, MD, Chair, Texas Tech Health Science Center El Paso
Disclosures: Nothing to disclose.

Nazli A. Janjua, MD, Vice Chair, Asia Pacific Comprehensive Stroke Institute
Disclosures: Nothing to disclose.

Norman Ajiboye, MD, Memorial Healthcare System
Disclosures: Nothing to disclose.

Steve Mario Cordina, MD, Patronus Neurology
Disclosures: Nothing to disclose.

Mesha Martinez, MD, Texas Children's - Baylor College of Medicine
Disclosures: Compensation for serving as a consultant (KOL) for VizAi, RapidAi, Cerenovus, Guerbet (KOL), and Siemens. Received compensation for serving on medical advisory board for Microvention.

Camilo R. Gomez, MD, MBA, University of Missouri Medical Center
Disclosures: Nothing to disclose.

Osman S. Kozak, MD, Abington Memorial Hospital
Disclosures: Nothing to disclose.

 Janhavi Modak, MD, Baystate Medical Center 
Disclosures: Spouse is employed by Vertex Pharmaceuticals and holds stock greater than $10,000 in the company.

Thanh Nguyen, MD, Boston University Medical Center 
Disclosures: Receives compensation from Aruna Bio, advisory board Brainomix; receives compensation from CREST-2, DSMB member of advisory board or data safety monitoring board; receives compensation as Associate Editor, Stroke.

Santiago Ortega Gutierrez, MD, University of Iowa Hospitals and Clinics 
Disclosures: Receives compensation from Medtronic Consulting; receives compensation for consulting from Medtronic Stryker; receives compensation for serving on a scientific advisory board for Medtronic NIH/NINDS ANIE study section; receives compensation for serving on speakers bureau for Medtronic Stryker Neurovascular; commercial interest greater than 5 percent of the company or greater than $10,000 in value for Gravity Motif; receives research support from NIH/NINDS PCORI. 

Jefferson T. Miley, MD, University of Texas at Austin 
Disclosures: Nothing to disclose. 

Pankajavalli Ramakrishnan, MD, PhD, MidHudson Regional Hospital 
Disclosures: Owns stock or an ownership interest from/with a commercial interest greater than 5 percent of the company or greater than $10,000 in value as investor in Basecamp Vascular, Bendit Technologies, Borvo Medical, FreeOx, Kandu, Radical, Serenity Medical, Sim&Cure, and Synchron. 

Staff Contact

Bryan Hagerla, Continuous Certification Manager
Disclosures: Nothing to disclose.
[email protected]
(612) 928-6326